comparemela.com

Latest Breaking News On - United therapeutics co - Page 14 : comparemela.com

Weil Company Inc Sells 246 Shares of United Therapeutics Co (NASDAQ:UTHR)

Weil Company Inc Sells 246 Shares of United Therapeutics Co (NASDAQ:UTHR)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Weil Company Inc Sells 246 Shares of United Therapeutics Co (NASDAQ:UTHR)

Weil Company Inc. lowered its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 0.5% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 48,020 shares of the biotechnology company’s stock after selling 246 shares during the quarter. United Therapeutics comprises 5.4% of Weil […]

L2 Asset Management LLC Has $131,000 Stock Holdings in United Therapeutics Co (NASDAQ:UTHR)

L2 Asset Management LLC trimmed its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 95.2% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 579 shares of the biotechnology company’s stock after selling 11,438 shares during the […]

Assenagon Asset Management S A Has $20 13 Million Holdings in United Therapeutics Co (NASDAQ:UTHR)

Assenagon Asset Management S.A. reduced its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 81.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 89,133 shares of the biotechnology company’s stock after selling 399,050 shares during the quarter. Assenagon Asset Management […]

United Therapeutics Co (NASDAQ:UTHR) Position Increased by LSV Asset Management

LSV Asset Management raised its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 1.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 383,068 shares of the biotechnology company’s stock after acquiring an additional 3,700 shares during the […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.